Serotherapy for peritonitis

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The authors reviewed 170 cases of peritonitis serotherapy with a fatal outcome in 18 cases (10.5%). To use serotherapy successfully, polyvalent serum of Escherichia coli, enterococci, and streptococci most commonly encountered in peritonitis should be prepared.

Full Text

Restricted Access

About the authors

М. Gündel

Author for correspondence.
Email: info@eco-vector.com
Germany

F. Süssbrich

Email: info@eco-vector.com
Germany

References

Supplementary files

Supplementary Files
Action
1. JATS XML

© 1934 Gündel М., Süssbrich F.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies